| In millions, except per share items | Jun-30-12 | Jun-30-11 | Jun-30-10 | Jun-30-09 | Jun-30-08 | Jun-30-07 | Jun-30-06 | Jun-30-05 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Perioperative Management Systems | 64.6 | 55.5 | 47.6 | | | | | |
| Medication Management Systems | 4.5 | 4.1 | 2.1 | | | | | |
| Total revenues | 64.6 | 55.5 | 47.6 | 40.7 | 39.4 | 41.2 | 37.9 | 36.6 |
| Revenue growth [+] | 16.3% | 16.6% | 17.0% | 3.2% | -4.3% | 8.8% | 3.6% | -0.3% |
| Perioperative Management Systems | 16.3% | 16.6% | | | | | | |
| Medication Management Systems | 9.8% | 97.2% | | | | | | |
| Cost of goods sold | 21.6 | 18.4 | 15.6 | 14.1 | 12.3 | 11.3 | 9.7 | 9.7 |
| Gross profit | 43.0 | 37.1 | 32.0 | 26.5 | 27.1 | 29.9 | 28.2 | 26.9 |
| Gross margin | 66.5% | 66.8% | 67.2% | 65.2% | 68.7% | 72.7% | 74.4% | 73.5% |
| Selling, general and administrative | 22.0 | 19.1 | 17.5 | 14.6 | 16.7 | 18.0 | 16.1 | 14.6 |
| Research and development | 5.7 | 4.5 | 4.9 | 3.9 | 4.2 | 4.1 | 4.3 | 3.5 |
| Other operating expenses | | | | | | 4.3 | 4.2 | 4.1 |
| EBIT [+] | 15.2 | 13.5 | 9.6 | 8.0 | 6.2 | 3.6 | 3.6 | 4.7 |
| EBIT growth | 12.3% | 41.1% | 19.9% | 28.6% | 71.6% | -0.6% | -21.9% | 6.4% |
| EBIT margin | 23.5% | 24.4% | 20.1% | 19.6% | 15.8% | 8.8% | 9.6% | 12.8% |
| Interest expense | | | | | | 0.0 | 0.0 | 0.1 |
| Interest expense | | | | | | 0.0 | 0.0 | 0.1 |
| Other income (expense), net | -4.1 | -4.6 | -4.9 | -5.5 | -4.9 | | 0.1 | 0.1 |
| Pre-tax income | 11.1 | 8.9 | 4.7 | 2.5 | 1.3 | 3.6 | 3.7 | 4.7 |
| Income taxes | 3.6 | 2.6 | 1.4 | 0.9 | 0.6 | 1.3 | 1.3 | 1.8 |
| Tax rate | 32.2% | 29.3% | 30.4% | 37.0% | 45.0% | 35.7% | 36.6% | 37.8% |
| Net income | 7.5 | 6.3 | 3.2 | 1.6 | 0.7 | 2.3 | 2.3 | 2.9 |
| Net margin | 11.7% | 11.3% | 6.8% | 3.9% | 1.8% | 5.6% | 6.1% | 8.0% |
| |
| Basic EPS [+] | $0.92 | $0.79 | $0.41 | $0.21 | $0.09 | $0.29 | $0.29 | $0.38 |
| Growth | 17.5% | 89.9% | 101.1% | 125.0% | -68.1% | -1.5% | -22.9% | -22.0% |
| Diluted EPS [+] | $0.90 | $0.77 | $0.41 | $0.20 | $0.09 | $0.28 | $0.28 | $0.36 |
| Growth | 16.8% | 88.5% | 106.2% | 125.4% | -68.2% | -1.7% | -22.0% | -18.4% |
| |
| Shares outstanding (basic) [+] | 8.2 | 8.0 | 7.8 | 7.7 | 8.0 | 8.1 | 8.0 | 7.8 |
| Growth | 2.1% | 2.2% | 2.4% | -3.9% | -2.0% | 1.4% | 2.8% | 4.4% |
| Shares outstanding (diluted) [+] | 8.4 | 8.2 | 8.0 | 8.0 | 8.3 | 8.4 | 8.3 | 8.2 |
| Growth | 2.7% | 3.0% | -0.1% | -4.1% | -1.4% | 1.7% | 1.7% | -0.3% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |